Elmiron MDL Advances with Case Management Conference

In December 2020, approximately 130 Elmiron lawsuits were consolidated into a multi-district litigation (MDL) to streamline pre-trial proceedings. On January 8, 2021, lawyers met with Judge Brian R. Martinotti, the New Jersey District Judge overseeing the litigation, via Zoom to hold a case management conference. As the litigation moves forward, the MDL aims to streamline discovery efforts common in each case, and come to a consensus on pre-trial rulings.

Plaintiffs in the Elmiron litigation contend that long-time use of the Janssen Pharmaceuticals drug left them with permanent vision problems. These problems include maculopathy, which is characterized by a progressive loss of central vision, usually bilateral, that greatly impairs functions.

Do I Have an Elmiron Lawsuit Claim?

Contact an experienced attorney if you believe your vision problems are a result of taking Elmiron. The attorneys at Grant & Eisenhofer P.A. are investigating Elmiron vision loss claims. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.